Literature DB >> 2877319

Enteric-coated prednisolone in cystic fibrosis.

J Gilbert, J M Littlewood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2877319     DOI： 10.1016/s0140-6736(86)90582-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 2.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

3.  Cystic fibrosis and allergic bronchopulmonary aspergillosis.

Authors:  E J Simmonds; J M Littlewood; E G Evans
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

4.  Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  J L Marchant; J O Warner; A Bush
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.